The DOI matches its Crossref record.
Nonalcoholic Steatohepatitis
Abstract
Nonalcoholic fatty liver disease (NAFLD) is being increasingly recognized as a common liver disorder that represents the hepatic manifestation of the metabolic syndrome, a variably defined aggregate of disorders related to obesity, insulin resistance, type II diabetes, hypertension and hyperlipidemia. Nonalcoholic steatohepatitis (NASH) is the progressive form of liver injury that carries a risk for progressive fibrosis, cirrhosis, and end-stage liver disease. Hepatocellular carcinoma (HCC) is a documented complication in an as yet unknown percentage of cases of NASH cirrhosis. The diagnosis of nonalcoholic steatohepatitis requires histopathologic evaluation because the lesions of parenchymal injury and fibrosis cannot be detected by imaging studies or laboratory tests. This article will briefly discuss prevalence studies and the pathophysiology of NAFLD and focus on current discussions related to the specific lesions in the pathology of NASH, including the challenges of pediatric NASH and NASH-related cirrhosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Adipose tissue can synthesize and release proinflammatory cytokines and adipokines, including leptin, adiponectin, and resistin; and these factors make up one of the driving mechanisms of IR (Brunt, 2004).”
From Akkermansia muciniphila alleviates high‐fat‐diet ‐related metabolic‐associated fatty liver disease by modulating gut microbiota and bile acids (2023) · cites this paper as Brunt, 2004
In the citing paper
“The assessment and severity of NASH is made histologically based on the patterns and degrees of hepatic steatosis, inflammation, and injury, in the absence of significant alcohol consumption.8”
From Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy† (2005) · cites this paper as [8]
Citations
Cited by
Sorted by citations
Items 401–480 of 480
The Morphological Spectrum of Alcoholic Liver Disease
Rabin, L. (1989) · Springer eBooks · doi:10.1007/978-1-4684-7041-3_11 · Cited by 5
Atsumi, Y., Yatsuji, S., Torii, N., Tokushige, K., Hashimoto, E., Yamamoto, M., & Shiratori, K. (2007) · Kanzo · doi:10.2957/kanzo.48.604 · Cited by 5
Geubel, A. P., Grégoire, V., Rahier, J., et al. (1988) · Liver International · doi:10.1111/j.1600-0676.1988.tb01008.x · Cited by 5
Kang, H., Kim, S., Park, S., Han, S., Kang, M., Kwon, S., & Ko, J. (2024) · Experimental Cell Research · doi:10.1016/j.yexcr.2024.114258 · Cited by 4
PRANDOTA, J. (2019) · Journal of Gastroenterology and Hepatology Research · doi:10.17554/j.issn.2224-3992.2019.07.824 · Cited by 4
K-Kutala, B., Bédossa, P., Guedj, J., et al. (2014) · Digestive and Liver Disease · doi:10.1016/j.dld.2014.12.010 · Cited by 4
Ono, H., Tanaka, A., Nakazato, K., Hasegawa, Y., Kim, K. I., Kim, S. R., Nakajima, K., & Nagamine, T. (2014) · The Kitakanto Medical Journal · doi:10.2974/kmj.64.13 · Cited by 4
NAFLD Prevalence in a Young Cadaveric Organ Donor Population
Jafarian, A., Ebrahimi, A. P., Ardalan, F. A., Dashti, H., Rahimi, M., Salehi, M., & Toosi, M. N. (2014) · Hepatitis Monthly · doi:10.5812/hepatmon.21574 · Cited by 4
Enfermedad hepática por infiltración grasa no alcohólica. La nueva pandemia del milenio
Santos, L., Hernández, G., Varón, A., Beltrán, Ó., Botero, R. C., & Mejía, G. (2010) · Redalyc (Universidad Autónoma del Estado de México) · Cited by 3
Ohbayashi, H., Naruse, T., Yamada, M., et al. (2006) · Journal of Rural Medicine · doi:10.2185/jrm.1.2_30 · Cited by 3
Rodríguez, R. C., & Valls, J. F. M. (2002) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0304-5412(02)70861-5 · Cited by 3
Nazmy, M., & Abd‐Elghany, M. I. (2015) · International Research Journal of Medicine and Medical Sciences · Cited by 3
Liver: Normal Anatomy, Imaging Techniques, and Diffuse Diseases
Boll, D. T., & Merkle, E. M. (2009) · Elsevier eBooks · doi:10.1016/b978-0-323-05375-4.50035-5 · Cited by 3
Hypertransaminasemia and severe hepatic steatosis without inflammation. A case report
Méndez‐Sánchez, N., Motola‐Kuba, D., Bahena-Aponte, J. A., Chávez-Tapia, N. C., Pichardo-Bahena, R., & Uribe, M. (2003) · Annals of Hepatology · doi:10.1016/s1665-2681(19)32132-5 · Cited by 3
Kalantari, H., Moradi, F., & Hassanzade, A. (2016) · Advanced Biomedical Research · doi:10.4103/2277-9175.186985 · Cited by 2
ALR, the multifunctional protein
Balogh, T., & Szarka, A. (2015) · Orvosi Hetilap · doi:10.1556/oh.2015.30119 · Cited by 2
Clinical trial: physical, psychological and social needs of patients
Hull, D. (2013) · British Journal of Nursing · doi:10.12968/bjon.2013.22.2.76 · Cited by 2
Hipertrigliceridemia, esteatosis hepática y riesgo cardiovascular
Brea, Á., Mosquera, D., Mostaza, J. M., Aranda, J. L., Argimón, J., Sanclemente, C., Mateo‐Gállego, R., Almagro, F., Plana, N., & Recarte, C. (2011) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2011.02.003 · Cited by 2
Transaminases profile in Algerian patients with type 2 diabetes mellitus
Gouri, A., Dekaken, A., Rouabhia, S., et al. (2012) · Immuno-analyse & Biologie Spécialisée · doi:10.1016/j.immbio.2012.07.021 · Cited by 2
Correlation between bright echogenic liver, elevated liver enzymes and liver histology
Kabir, I. M., Alam, M., Mahmuduzzaman, M., et al. (2012) · Journal of Dhaka National Medical College & Hospital · doi:10.3329/jdnmch.v17i1.12184 · Cited by 2
Histopathological Evaluation of Non-Alcoholic Fatty Liver Disease: Mini-Review of Literature
de Andrade, R. S. B., Rodrigues, A. A., França, L. F. D. C., et al. (2018) · Journal of Gastroenterology and Hepatology Research · doi:10.17554/j.issn.2224-3992.2018.07.752 · Cited by 2
Liver Biopsy (Quality and Use of Gun)
Strassburg, C. P., & Manns, M. P. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0881-3.00012-7 · Cited by 2
Lei, P., Zhang, P., Xu, H., et al. (2020) · Journal of X-Ray Science and Technology · doi:10.3233/xst-200676 · Cited by 2
“However, there are exceptions: in some cases, alcoholic fatty liver evolves directly to cirrhosis instead of passing through NASH [31].”
A prospective study showing poor prognosis in Japanese NASH patients with fibrosis stage F3-4
Kawanaka, M., Nishino, K., Oka, T., et al. (2012) · Institutional Repositories DataBase (IRDB) · Cited by 2
Cirrhosis and portal hypertension
Pai, R. K., & Brunt, E. M. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1454-8.00070-9 · Cited by 2
Self-citationLiver Transplantation for Nonalcoholic Fatty Liver Disease
Charlton, M. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-028-1_10 · Cited by 2
Bataller, R. A., & Brenner, D. A. (2009) · Wiley eBooks · doi:10.1002/9780470747919.ch29 · Cited by 2
Song, X., Li, D., Sun, J., Zhang, X., Wang, L.-S., & Chen, F. (2024) · Food Science and Human Wellness · doi:10.26599/fshw.2024.9250299 · Cited by 2
Gao, Z., Lin, X., Chen, G., et al. (2015) · Chinese Medicine · doi:10.4236/cm.2015.62013 · Cited by 1
Lu, Y., Jia, W. P., Xu, L., et al. (2014) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-014-1375-0 · Cited by 1
HEPATIC STEATOSIS: AN AETIOHISTOPATHOLOGICAL STUDY
Metkar, G. S. (2016) · Journal of Evolution of Medical and Dental Sciences · doi:10.14260/jemds/2016/808 · Cited by 1
Alcoholic and Non-Alcoholic Fatty Liver Diseases
Kanel, G. C., & Korula, J. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0765-6.10004-7 · Cited by 2
Inflammatory and infectious diseases of the liver
Moreira, R. K., & Washington, K. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0925-4.00028-6 · Cited by 1
Kazi, T. G., Arain, S. A., & Afridi, H. I. (2016) · Pharmaceutica Analytica Acta · doi:10.4172/2153-2435.1000510 · Cited by 1
Metabolic Syndrome, Diabetes and Nonalcoholic Steatohepatitis
Kyrou, I., Haukeland, J. W., Bhala, N. B., & Kumar, S. (2009) · Wiley eBooks · doi:10.1002/9781444307627.ch16 · Cited by 1
Esteatose hepática em mulheres obesas
Araújo, L. M. B., Santiago, R., Oliveira, D. S. A., & Ds, N. (1998) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27301998000600008 · Cited by 1
Kobayashi, N., Masuzaki, H., Tanaka, T., Yasue, S., Ishii, T., Tomita, T., Miyawaki, T., Komeda, T., Fukuda, Y., Kusakabe, T., et al. (2009) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2008.11.002 · Cited by 1
Bernal-Reyes, R., & Bernal-Serrano, D. (2006) · Revista Portuguesa de Pneumologia · Cited by 1
The Role of Liver Biopsy in the Management of Patients with Liver Disease
Wong, F. S.-H. (2003) · Canadian Journal of Gastroenterology · doi:10.1155/2003/837069 · Cited by 1
Strassburg, C. P., & Manns, M. P. (2006) · Elsevier eBooks · doi:10.1016/b978-1-4160-3258-8.50017-6 · Cited by 1
Classifications, Scoring Systems and Morphometry in Liver Pathology
Bédossa, P., & Paradis, V. (2007) · doi:10.1002/9780470691861.ch4b
Histology and Pathology of Normal and Diseased Liver
Paradis, V., & Weber, A. (2009) · Wiley eBooks · doi:10.1002/9781444317053.ch3
La patologia epatica cronica nell’anziano
Santo, P. D. (2011) · La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine · doi:10.1007/s13631-011-0017-9
Novel mechanisms of type I collagen regulation in liver fibrosis
Fritz, D. (2008)
Effect of the ligands of thyroid hormone receptor on non-alcoholic fatty liver disease
Kowalik, M. A. (2009) · VEprints - Universita degli Studi di Cagliari
Feng, T. T. Q. (2012) · TSpace (University of Toronto)
La stéato-hépatite non alcoolique. Influence de la nutrition, de la physiopathologie au traitement
Quilliot, D., Böhme, P., & Ziegler, O. (2011) · Springer eBooks · doi:10.1007/978-2-8178-0237-4_5
Kornacki, S., & West, A. B. (2006) · Advances in Anatomic Pathology · doi:10.1097/01.pap.0000213009.56103.40
Esteatosis hepática no alcohólica en la infección por el virus de la inmunodeficiencia humana
Merchante, N., Mira, J. A. L., & Pineda, J. A. (2009) · Medicina Clínica · doi:10.1016/j.medcli.2008.10.033
Afección hepática en adolescente con diabetes mellitus tipo 1 y mal control metabólico
Fuentes, E. D., Romero, M. S., García-Doncel, L. G., et al. (2008) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(08)70673-9
A case of non-alcoholic steatohepatitis due to malnutrition.
開, 山., 千晃, 奥., 啓弘, 鈴., Kobayashi, Y., OSADA, T., Tomoe, M., TOYAMA, H., HAYASHI, T., YOSHIDA, H., TAKAHASHI, Y., et al. (1998) · Kanzo · doi:10.2957/kanzo.39.18
Leitsymptome und Differenzialdiagnostik
Lang, T., & Rodeck, B. (2013) · Springer eBooks · doi:10.1007/978-3-642-24710-1_15
Pretorius, J. (2012) · SUNScholar (Stellenbosch University)
生活習慣と肝臓病:診断と治療の進歩 IV.非アルコール性脂肪肝炎(NASH)5.診断へのアプローチ 3)病理診断
史朗, 前., 正人, 米., & 淳, 中. (2006) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.95.76
Nazmy, M., & Abd‐Elghany, M. I. (2014) · Bulletin of Pharmaceutical Sciences Assiut · doi:10.21608/bfsa.2014.65791
Mendoza, P. G. L., Tsui, W. M. S., Ho, L., Wayne, M. G., Kagen, A., & Theise, N. D. (2016) · Philippine Journal of Pathology · doi:10.21141/pjp.2016.008
Disorders of the Hepato-Biliary System in the Elderly
Nagaratnam, N., Nagaratnam, K., & Cheuk, G. (2016) · Springer eBooks · doi:10.1007/978-3-319-25787-7_4
Lowe, L. H. (2008) · Elsevier eBooks · doi:10.1016/b978-0-323-04520-9.50122-2
Imaging Biomarkers in Clinical Trials
Liu, Y., & Waterton, J. C. (2016) · Springer eBooks · doi:10.1007/978-3-319-43504-6_21
Hepatosteatosis may reveal heterozygous familial hypobetalipoproteinemia
Mazokopakis, E. E., Karefilaki, S., Syros, P. K., & Lioudaki, E. (2013)
Review Article Conventional Drugs and Herbal Medicines Showing Hepatotoxicity: A Review
Rastogi, S., Bhalla, V., & Arora, V. (2015)
MODELO EXPERIMENTAL DE ESTEATOHEPATITE NÃO-ALCOÓLICA COM DIETA DEFICIENTE EM
Zamin, I., de Mattos, Â. A., Migon, E., Soares, E., Luiz, M. B., & Perry, S. (2009)
Clinical pharmacology profile of care in Hepatology clinic
Passos, T. R., Santos, F. S., Martins, M. C., et al. (2017) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.63.05.401
Gold nanoparticles to ameliorate obesity related glucose intolerance
Ng, J. P. M. (2016) · UTS ePRESS (University of Technology Sydney)
de Valparaíso, U., Mariane Lutz, R., Avaria, R., de Valparaíso, U., Luna, L., & de Valparaíso, U. (2018) · Perspectivas en Nutrición Humana · doi:10.17533/udea.penh.v20n1a02
Kirsch, R., Hall, P. D. L. Μ., George, J., McCullough, A. J., & Farrell, G. C. (2004) · doi:10.1002/9780470987438.ch24
Cirrhosis and Portal Hypertension: Pathologic Aspects
WANG, H. L., & BRUNT, E. M. (2007) · Elsevier eBooks · doi:10.1016/b978-1-4160-3256-4.50107-1 · Cited by 1
Self-citationCorte, C. D., Mosca, A., Alterio, A., Comparcola, D., Ferretti, F., & Nobili, V. (2017) · Contemporary Endocrinology · doi:10.1007/978-3-319-68192-4_26
(2006) · Elsevier eBooks · doi:10.1016/b978-343756530-4.50015-4
Hypoxia-inducible factor-1α-mediated SERPINE-1 expression in ischemic urinary bladder
Choi, B., Cho, T. J., Lee, T., et al. (2023) · Molecular & Cellular Toxicology · doi:10.1007/s13273-023-00334-5
“…and Plod2, which can be induced by hypoxic stress as well as Hif-1α-mediated expression, are related to pathological progressive hypertrophy and/or fibrosis, as reported in other tissues such as the kidney, liver, and heart (Eddy 2000; Brunt 2004; Bataller and Brenner 2005; Ma and Fogo 2009).”
BackgroundALCOHOLIC AND NON-ALCOHOLIC FATTY LIVER DISEASES
Kanel, G. C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-82533-7.00005-3
The Adaptive Immune System and Liver Toxicity
Holt, M. R., & Ju, C. H. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-046884-6.01030-7
Clinicometabolic profile of fatty liver disease in obese children: a study from Kashmir
Ahmed, S. S., Masood, A., Paul, B. A., et al. (2025) · International Journal of Contemporary Pediatrics · doi:10.18203/2349-3291.ijcp20254182
Mebarki, S. (2013) · theses.fr (ABES) · doi:10.70675/4ef645b5z7dc2z4553zac58zecf84e9d2c83
Chen, T.-T., Gou, H.-X., & Luo, Z.-L. (2026) · World Journal of Hepatology · doi:10.4254/wjh.120134
ALTERED PHARMACOKINETICS AND DRUG DOSING IN OBESE PATIENTS: A TRADITIONAL REVIEW
Bakay, Z., Aksoy, M., Özkanlı, Ö. F., & Sancar, M. (2026) · Ankara Universitesi Eczacilik Fakultesi Dergisi · doi:10.33483/jfpau.1706303
Efeito da fibra dietética e do exercício físico resistido na doença hepática gordurosa
Peresi, V. L. (2011) · Americanae (AECID Library)
Metadata
- Authors
- Brunt, E. M.
- Affiliations
- Saint Louis University Hospital (US)
- Corresponding author
- Elizabeth M. Brunt
- ORCID
- Elizabeth M. Brunt
- Venue
- Seminars in Liver Disease
- Publisher
- Georg Thieme Verlag KG
- Published
- 2004-01
- Volume
- 24
- Issue
- 1
- Pages
- 3-20
- ISSN
- 0272-8087 (ISSN-L)
- 1098-8971
- OpenAlex
- W3149847267
- Cited by
- 481
- References
- 0
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 9 · 2023: 8 · 2022: 4 · 2021: 6 · 2020: 13 · 2019: 4 · 2018: 18 · 2017: 14 · 2016: 24 · 2015: 25 · 2014: 26 · 2013: 22 · 2012: 31
- FWCI
- 29.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Seminars in Liver Disease (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- nonalcoholic steatohepatitis, non-alcoholic fatty liver disease, metabolic syndrome, liver fibrosis, liver cirrhosis, hepatocellular carcinoma, histopathology, pathophysiology, prevalence, insulin resistance, obesity
- MeSH terms
- Adolescent, Adult, Child, Fatty Liver, Fatty Liver, Alcoholic, Carcinoma, Hepatocellular, Humans, Liver Cirrhosis, Liver Neoplasms, Prevalence, Metabolic Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review